...
首页> 外文期刊>Diabetes care >Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the insulin delivery system rating questionnaire.
【24h】

Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the insulin delivery system rating questionnaire.

机译:评估与健康相关的生活质量和治疗偏好的工具的有效性和可靠性:胰岛素输送系统评级问卷。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To provide a preliminary assessment of the validity and reliability of a new measure of health-related quality of life (HRQOL) and treatment preference for insulin delivery systems. RESEARCH DESIGN AND METHODS: Study participants were 197 adults with type 1 or type 2 diabetes who completed the Insulin Delivery System Rating Questionnaire (IDSRQ), a self-administered questionnaire developed for this study. The IDSRQ assessed patient perceptions of treatment satisfaction, impact of treatment on daily activities, clinical efficacy, diabetes-related worries and social burdens, psychological well-being, and overall treatment system preference of patients using continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI). RESULTS: The IDSRQ subscales had acceptable reliability (alpha = 0.67-0.92, median 0.82) and test-retest correlations (intraclass correlation coefficient 0.67-0.94, median 0.88). Floor effects (0-10%, median 0%) and ceiling effects (0-18%, median 4%) were minimal. There were statistically significant differences (P < 0.05) between patients using CSII and MDI on all IDSRQ subscales except psychological well-being (P = 0.096); differences in means were 0.3-1.4 SD units (median 0.9). Multiple regression analysis (controlling for age, sex, and type of diabetes) showed that treatment satisfaction, perceived clinical efficacy, and psychological well-being were independently associated with overall treatment preference and accounted for half of the difference in preference between CSII and MDI patients. CONCLUSIONS: Preliminary findings suggest that the IDSRQ is a valid and reliable measure of HRQOL and treatment preferences for insulin delivery systems. The subscales are comprehensive, sensitive to differences in user populations, and account for most of the preference for a particular insulin delivery system.
机译:目的:初步评估一种新的健康相关生活质量(HRQOL)措施和胰岛素输送系统治疗偏好的有效性和可靠性。研究设计和方法:研究参与者为197位1型或2型糖尿病成人,他们完成了针对本研究开发的自我管理问卷“胰岛素输送系统评分问卷”(IDSRQ)。 IDSRQ使用连续皮下胰岛素输注(CSII)和每日多次对患者的治疗满意度,治疗对日常活动的影响,临床疗效,糖尿病相关的忧虑和社会负担,心理健康以及患者对总体治疗系统的偏好进行了评估注射(MDI)。结果:IDSRQ子量表具有可接受的可靠性(α= 0.67-0.92,中位数0.82)和重测相关性(类内相关系数0.67-0.94,中位数0.88)。地板效应(0-10%,中位数0%)和天花板效应(0-18%,中位数4%)最小。除心理健康外,所有IDSRQ分量表上使用CSII和MDI的患者之间在CSII和MDI之间存在统计学差异(P <0.05);(P = 0.096)。均值差异为0.3-1.4 SD单位(中位数0.9)。多元回归分析(控制年龄,性别和糖尿病类型)显示,治疗满意度,感知的临床疗效和心理健康状况与总体治疗偏好独立相关,占CSII和MDI患者偏好偏好差异的一半。结论:初步研究结果表明,IDSRQ是一种有效,可靠的衡量HRQOL和胰岛素输送系统治疗偏好的方法。该分量表是全面的,对用户群体的差异敏感,并解释了对特定胰岛素输送系统的大多数偏爱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号